Can Psychedelics Radically Change SUD Treatment?
Psychiatric News March 20, 2020 Katie O’connor
Though the field is young, psychedelics appear to hold promise as a treatment for addiction, even as barriers to research persist. Researchers around the world are investigating how drugs such as LSD, MDMA (also known as ecstasy), ketamine, and psilocybin (the active ingredient in magic mushrooms) can treat patients with substance use disorders (SUD). Though there is still a lot to learn, early...
DOI: 10.1176/appi.pn.2020.2a12 (opens in new tab)
Psilocybin
MDMA
Addiction
Hallucinogen
+1